Clinical trial
3-AP in Treating Patients With Previously Untreated Locally Recurrent or…
NCT00075660 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00075660 |
|---|---|
| Title | 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma |
| Official title | A Phase II Study of Triapine (NSC 663249) in Previously Untreated Patients With Recurrent Renal Cell Carcinoma |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Drug |
| Interventions | triapine |
| Enrollment | 19 |
| Start date | May 11, 2004 |
| Primary completion | Oct 4, 2005 |
| Completion | Sep 22, 2008 |
| First posted | Jan 12, 2004 |
| Last update posted | Aug 4, 2023 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: